titlesubmit dateissue date
Now showing items 1-8 of 8
EWS-FLI1 confers exquisite sensitivity to NAMPT inhibition in Ewing sarcoma cells
EWS-FLI1 impairs aryl hydrocarbon receptor activation by blocking tryptophan breakdown via the kynurenine pathway.
EWS-FLI1-mediated suppression of the RAS-antagonist Sprouty 1 (SPRY1) confers aggressiveness to Ewing sarcoma
Genome-wide association study identifies multiple new loci associated with Ewing sarcoma susceptibility
Hippo pathway effectors YAP1/TAZ induce an EWS-FLI1-opposing gene signature and associate with disease progression in Ewing sarcoma.
Lysyl oxidase is downregulated by the EWS/FLI1 oncoprotein and its propeptide domain displays tumor supressor activities in Ewing sarcoma cells
The role of miR-17-92 in the miRegulatory landscape of Ewing sarcoma
The second European interdisciplinary Ewing sarcoma research summit--A joint effort to deconstructing the multiple layers of a complex disease